New therapeutic approaches in sepsis: A critical review

L. A. Eidelman; R. Pizov; C. L. Sprung

doi:10.1007/BF01740766

New therapeutic approaches in sepsis: A critical review

L. A. Eidelman, R. Pizov, C. L. Sprung

Research output: Contribution to journal › Article › peer-review

Abstract

This paper reviews several recent, randomized, double-blind, placebo-controlled trials of monoclonal antibodies against endotoxin, interleukin-1 receptor antagonist (IL-1 ra), and monoclonal antibody against tumor necrosis factor (TNF) in sepsis.

Original language	English
Pages (from-to)	S269-S272
Journal	Intensive Care Medicine
Volume	21
Issue number	2 Supplement
DOIs	https://doi.org/10.1007/BF01740766
State	Published - Nov 1995
Externally published	Yes

Keywords

Endotoxin
Interleukin-1 receptor antagonist
Mediators
Monoclonal antibodies
Sepsis
Tumor necrosis factor

Access to Document

10.1007/BF01740766

Cite this

@article{00deb5f2fd1e4c13b63afbddb9d56a98,

title = "New therapeutic approaches in sepsis: A critical review",

abstract = "This paper reviews several recent, randomized, double-blind, placebo-controlled trials of monoclonal antibodies against endotoxin, interleukin-1 receptor antagonist (IL-1 ra), and monoclonal antibody against tumor necrosis factor (TNF) in sepsis.",

keywords = "Endotoxin, Interleukin-1 receptor antagonist, Mediators, Monoclonal antibodies, Sepsis, Tumor necrosis factor",

author = "Eidelman, {L. A.} and R. Pizov and Sprung, {C. L.}",

year = "1995",

month = nov,

doi = "10.1007/BF01740766",

language = "אנגלית",

volume = "21",

pages = "S269--S272",

journal = "Intensive Care Medicine",

issn = "0342-4642",

publisher = "Springer Verlag",

number = "2 Supplement",

}

TY - JOUR

T1 - New therapeutic approaches in sepsis

T2 - A critical review

AU - Eidelman, L. A.

AU - Pizov, R.

AU - Sprung, C. L.

PY - 1995/11

Y1 - 1995/11

N2 - This paper reviews several recent, randomized, double-blind, placebo-controlled trials of monoclonal antibodies against endotoxin, interleukin-1 receptor antagonist (IL-1 ra), and monoclonal antibody against tumor necrosis factor (TNF) in sepsis.

AB - This paper reviews several recent, randomized, double-blind, placebo-controlled trials of monoclonal antibodies against endotoxin, interleukin-1 receptor antagonist (IL-1 ra), and monoclonal antibody against tumor necrosis factor (TNF) in sepsis.

KW - Endotoxin

KW - Interleukin-1 receptor antagonist

KW - Mediators

KW - Monoclonal antibodies

KW - Sepsis

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0029401031&partnerID=8YFLogxK

U2 - 10.1007/BF01740766

DO - 10.1007/BF01740766

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 8636535

AN - SCOPUS:0029401031

VL - 21

SP - S269-S272

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

IS - 2 Supplement

ER -

New therapeutic approaches in sepsis: A critical review

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this